From: Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
Baseline | After treatment | P value | |||
---|---|---|---|---|---|
Median | Range | Median | Range | ||
Patients who achieved CR | |||||
High expression group (n = 6) | 29.84 | 10.91–255.82 | 5.53 | 1.21–14.22 | 0.024 |
Low expression group (n = 4) | 1.04 | 0.46–6.71 | 12.8 | 0.05–38.32 | 0.144 |
Failed CR (n = 6) | 6.55 | 0.57–40.22 | 1.01 | 0.92–30.57 | 0.249 |